Nintedanib 69097-0641
Product NDC
69097-0641- Manufacturer
- Cipla Usa Inc.
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 2, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA212609
Need to source Nintedanib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Nintedanib Esylate | 100 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Protein Kinase Inhibitors [MoA]
Packaging Options(1)
60 CAPSULE in 1 BOTTLE (69097-641-03)